Nanobody-based binding assay for the discovery of potent inhibitors of CFTR inhibitory factor (Cif)

Lead identification and optimization are essential steps in the development of a new drug. It requires cost-effective, selective and sensitive chemical tools. Here, we report a novel method using nanobodies that allows the efficient screening for potent ligands. The method is illustrated with the cy...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Anal Chim Acta
Egile Nagusiak: Vasylieva, Natalia, Kitamura, Seiya, Dong, Jiexian, Barnych, Bogdan, Hvorecny, Kelli L., Madden, Dean R., Gee, Shirley J., Wolan, Dennis W., Morisseau, Christophe, Hammock, Bruce D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6426448/
https://ncbi.nlm.nih.gov/pubmed/30832908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.aca.2018.12.060
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak